» Articles » PMID: 24175005

Prior Effective Sample Size in Conditionally Independent Hierarchical Models

Overview
Journal Bayesian Anal
Date 2013 Nov 1
PMID 24175005
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Prior effective sample size (ESS) of a Bayesian parametric model was defined by Morita, et al. (2008, , 595-602). Starting with an -information prior defined to have the same means and correlations as the prior but to be vague in a suitable sense, the ESS is the required sample size to obtain a hypothetical posterior very close to the prior. In this paper, we present two alternative definitions for the prior ESS that are suitable for a conditionally independent hierarchical model. The two definitions focus on either the first level prior or second level prior. The proposed methods are applied to important examples to verify that each of the two types of prior ESS matches the intuitively obvious answer where it exists. We illustrate the method with applications to several motivating examples, including a single-arm clinical trial to evaluate treatment response probabilities across different disease subtypes, a dose-finding trial based on toxicity in this setting, and a multicenter randomized trial of treatments for affective disorders.

Citing Articles

The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design.

Benest J, Rhodes S, Evans T, White R Vaccines (Basel). 2022; 10(11).

PMID: 36366347 PMC: 9693615. DOI: 10.3390/vaccines10111838.


A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.

Zhang W, Pan Z, Yuan Y J Biopharm Stat. 2022; 32(3):359-372.

PMID: 35679137 PMC: 9378566. DOI: 10.1080/10543406.2022.2080700.


Calibrated dynamic borrowing using capping priors.

Ling S, Hobbs B, Kaizer A, Koopmeiners J J Biopharm Stat. 2022; 31(6):852-867.

PMID: 35129422 PMC: 9940118. DOI: 10.1080/10543406.2021.1998100.


Borrowing Strength and Borrowing Index for Bayesian Hierarchical Models.

Xu G, Zhu H, Lee J Comput Stat Data Anal. 2020; 144.

PMID: 32341613 PMC: 7185234. DOI: 10.1016/j.csda.2019.106901.


Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.

Rosner G, Muller P Biometrics. 2020; 76(2):599-601.

PMID: 32251527 PMC: 8487458. DOI: 10.1111/biom.13254.


References
1.
Morita S, Thall P, Muller P . Determining the effective sample size of a parametric prior. Biometrics. 2007; 64(2):595-602. PMC: 3081791. DOI: 10.1111/j.1541-0420.2007.00888.x. View

2.
Gray R . A Bayesian analysis of institutional effects in a multicenter cancer clinical trial. Biometrics. 1994; 50(1):244-53. View

3.
OQuigley J, Pepe M, Fisher L . Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics. 1990; 46(1):33-48. View

4.
Berlin J, Colditz G . The role of meta-analysis in the regulatory process for foods, drugs, and devices. JAMA. 1999; 281(9):830-4. DOI: 10.1001/jama.281.9.830. View

5.
Thall P, Wathen J, Bekele B, Champlin R, Baker L, Benjamin R . Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes. Stat Med. 2003; 22(5):763-80. DOI: 10.1002/sim.1399. View